Mosaic Variant in Unilateral Woolly Hair in a Girl With PIK3CA ‐Related Overgrowth Spectrum
- 1 January 2026
- journal article
- case report
- Published by Wiley in Congenital Anomalies
- Vol. 66 (1) , e70066
Abstract
The phosphatidylinositol‐3‐kinase (PI3K)‐AKT‐mTOR pathway plays a central role in cellular growth and survival, and somatic activating variants in PIK3CA cause PIK3CA‐related overgrowth spectrum (PROS). Because these variants arise postzygotically, affected individuals exhibit somatic mosaicism, making molecular diagnosis challenging, particularly when only peripheral blood is available. We report an infant with PROS presenting with hemimegalencephaly, facial infiltrating lipomatosis, epidermal nevi, and unilateral woolly hair. A hotspot PIK3CA variant (c.1633G>A, p.Glu545Lys) was identified in the resected brain tissue but not in the peripheral blood. Notably, the variant was detected in DNA extracted from hair follicles of curly hair on the affected side of the scalp, whereas it was absent in follicles from straight hair on the contralateral side. Droplet digital PCR demonstrated variant allele fractions of 24.7%–27.6% in brain tissue and 32.3% in curly hair. These findings highlight the utility of hair follicles as a minimally invasive and accessible source of DNA for detecting somatic mosaic variants in PROS. The spatial concordance between genotype and hair phenotype suggests a possible association between PIK3CA mosaicism and localized hair abnormalities, although causality remains to be established.Keywords
This publication has 11 references indexed in Scilit:
- A standard of care for individuals with PIK3CA‐related disorders: An international expert consensus statementClinical Genetics, 2021
- Dermatologic findings in individuals with genetically confirmed Proteus syndromePediatric Dermatology, 2021
- Hypertrichotic patches as a mosaic manifestation of Proteus syndromeJournal of the American Academy of Dermatology, 2021
- Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testingGenetics in Medicine, 2017
- The PI3K Pathway in Human DiseaseCell, 2017
- An improved digital polymerase chain reaction protocol to capture low‐copy KRAS mutations in plasma cell‐free DNA by resolving ‘subsampling’ issuesMolecular Oncology, 2017
- PIK3CA‐related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluationAmerican Journal of Medical Genetics Part A, 2014
- De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephalyNature Genetics, 2012
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004